Ngā hua rapu - Witjes, Han
- E whakaatu ana i te 1 - 10 hua o te 10
-
1
-
2
Meta‐Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority mā Witjes, Han, Khatri, Amit, Diderichsen, Paul M., Mandema, Jaap, Othman, Ahmed A.
I whakaputaina 2019Text -
3
Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulation mā Frattarelli, John L, Hillensjö, Torbjörn, Broekmans, Frank J, Witjes, Han, Elbers, Jolanda, Gordon, Keith, Mannaerts, Bernadette
I whakaputaina 2013Text -
4
Population pharmacokinetics and exposure‐response of osimertinib in patients with non‐small cell lung cancer mā Brown, Kathryn, Comisar, Craig, Witjes, Han, Maringwa, John, de Greef, Rik, Vishwanathan, Karthick, Cantarini, Mireille, Cox, Eugène
I whakaputaina 2017Text -
5
Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol mā Broekmans, Frank J., Verweij, Pierre J.M., Eijkemans, Marinus J.C., Mannaerts, Bernadette M.J.L., Witjes, Han
I whakaputaina 2014Text -
6
Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing mā Lommerse, Jos, Clarke, Diana, Kerbusch, Thomas, Merdjan, Henri, Witjes, Han, Teppler, Hedy, Mirochnick, Mark, Acosta, Edward P., Wenning, Larissa, Nachman, Sharon, Chain, Anne
I whakaputaina 2019Text -
7
Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia mā Du, Lihong, Wenning, Larissa, Migoya, Elizabeth, Xu, Yan, Carvalho, Brendan, Brookfield, Kathleen, Witjes, Han, de Greef, Rik, Lumbiganon, Pisake, Sangkomkamhang, Ussanee, Titapant, Vitaya, Duley, Lelia, Long, Qian, Oladapo, Olufemi T.
I whakaputaina 2018Text -
8
Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia: A Population Pharmacokinetic Exposure‐Response Modeling and Simulation Study mā Du, Lihong, Wenning, Larissa A., Carvalho, Brendan, Duley, Lelia, Brookfield, Kathleen F., Witjes, Han, de Greef, Rik, Lumbiganon, Pisake, Titapant, Vitaya, Kongwattanakul, Kiattisak, Long, Qian, Sangkomkamhang, Ussanee S., Gülmezoglu, Ahmet M., Oladapo, Olufemi T.
I whakaputaina 2019Text -
9
998. Forward and Reverse Translational Approaches to Predict Efficacy of the Neutralizing Respiratory Syncytial Virus (RSV) Antibody MK-1654 mā Maas, Brian M, Lommerse, Jos, Plock, Nele, Railkar, Radha, Amy Cheung, S Y, Caro, Luzelena, Chen, Jingxian, Liu, Wen, Zhang, Ying, Huang, Qinlei, Gao, Wei, Qin, Li, Meng, Jie, Witjes, Han, Schindler, Emilie, Guiastrennec, Benjamin, Bellanti, Francesco, Spellman, Daniel, Roadcap, Brad, Kalinova, Mariya, Fok-Seang, Juin, Catchpole, Andrew P, Espeseth, Amy, Aubrey Stoch, S, Lai, Eseng, Vora, Kalpit A, Aliprantis, Antonios O, Sachs, Jeffrey R
I whakaputaina 2021Text -
10
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis mā Maas, Brian M., Lommerse, Jos, Plock, Nele, Railkar, Radha A., Cheung, S.Y. Amy, Caro, Luzelena, Chen, Jingxian, Liu, Wen, Zhang, Ying, Huang, Qinlei, Gao, Wei, Qin, Li, Meng, Jie, Witjes, Han, Schindler, Emilie, Guiastrennec, Benjamin, Bellanti, Francesco, Spellman, Daniel S., Roadcap, Brad, Kalinova, Mariya, Fok-Seang, Juin, Catchpole, Andrew P., Espeseth, Amy S., Stoch, S. Aubrey, Lai, Eseng, Vora, Kalpit A., Aliprantis, Antonios O., Sachs, Jeffrey R.
I whakaputaina 2021Text